Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Rights of TPL/PTSC in the event of PDS sale

Rights of TPL/PTSC in the event of PDS sale

posted on Jan 15, 2008 02:30AM

I believe that both TPL/PTSC have permanent rights to the MMP Portfolio under the agreement with PDS. In the event of a sale, I believe that those rights would remain, or at least be included in the sale package if not.

 

 

Be well

Share
New Message
Please login to post a reply